NCT03640910

Brief Summary

The aim of this randomized controlled trial is to compare peri-implant tissue health, number of complications, and patient's preference between two unsplinted overdenture attachments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 29, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 21, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2020

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

2.1 years

First QC Date

March 29, 2018

Last Update Submit

February 7, 2021

Conditions

Keywords

Dental implantsOverdentureRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Implant and prosthetic success rate

    An implant will be considered a failure if it presented with any mobility, assessed by tapping or rocking the implant head with the metallic handles of two instruments, progressive marginal bone loss or infection, and any mechanical complications rendering the implant unusable, although still mechanically stable in the bone.

    Up to 5 years after implant placement

Secondary Outcomes (2)

  • Marginal bone loss

    Up to 5 years after implant placement

  • Oral Health Impact Profile

    Up to 5 years after implant placement

Study Arms (2)

OT Equators® (Rhein83)

EXPERIMENTAL

After gingival healing the newest low-profile OT Equators® (Rhein83) will be screwed on to the implants, using the OT Equator® square screwdriver (Rhein83), with a torque range of 22-25 N cm. The cuff heights ranged from 0.5 to 7.0 mm, depending on the height of the transition zone of each implant, easily measured using the color-coded millimeter Cuff Height Measurer Gauge (Rhein83) after healing abutment removal.

Device: OT Equators® (Rhein83)

Locator® (Zest)

ACTIVE COMPARATOR

The low-profile attachments Locator® (Zest) will be screwed on to the implants, using the Locator® screwdriver (Zest), with a torque range of 20-25 N cm. The cuff heights of 2.5 or 4.0 mm, depending on the height of the transition zone of each implant, measured using the deep probe of the implant line after healing abutment removal.

Device: Locator® (Zest)

Interventions

Attachment systems to retain an implant overdenture

OT Equators® (Rhein83)

Attachment systems to retain an implant overdenture

Locator® (Zest)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any healthy individual (ASA 1 and 2)( (Dexter and Thompson, 2001), aged 18 years or older at the time of enrollment, with complete edentulous mandible, or a failing dentition in the mandible, scheduled to receive an implant supported overdenture, will be considered eligible for the study.

You may not qualify if:

  • General contraindications to oral surgery, pregnancy or nursing, intravenous bisphosphonate therapy, alcohol or drug abuse, heavy smoking (≥ 20 cigarettes/day), radiation therapy to the head or neck region within the last five years, parafunctional activity, untreated periodontitis, and allergy or adverse reactions to the restorative materials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Studio Dr. Marco Tallarico

Rome, 00151, Italy

Location

Study Officials

  • Marco Tallarico, Dr

    University of Aldent, Tirana

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal advisor

Study Record Dates

First Submitted

March 29, 2018

First Posted

August 21, 2018

Study Start

January 1, 2018

Primary Completion

January 30, 2020

Study Completion

December 31, 2020

Last Updated

February 9, 2021

Record last verified: 2021-02

Locations